Replies to post #762691 on NorthWest Biotherapeutics Inc (NWBO)

[DJPele]

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176091941

[CherryTree1]

Here is an AI Overview from google: "british government pushing biotech industry"

AI Overview
Learn more
The British government is actively promoting the biotech industry through various funding initiatives, tax incentives, and a focus on innovation and research. This includes specific strategies to foster engineering biology and leverage AI in life sciences, aiming to boost the UK's position as a global leader in these areas.
Here's a more detailed look at how the UK government is pushing the biotech industry:
1. Funding and Investment:
Life Sciences Innovative Manufacturing Fund (LSIMF):
This fund provides capital grants to support investments in manufacturing for drugs and medical technologies, helping the UK safeguard against future health emergencies.
Public-private investment:
The UK government has launched a public-private investment initiative, according to European Medical Journal, aiming to advance the pharmaceutical and life sciences sectors and provide NHS patients with faster access to new treatments.
Investment in Engineering Biology:
A national vision for engineering biology, according to GOV.UK, outlines a £2 billion plan to harness the power of biology for new medical therapies, crop varieties, and eco-friendly fuels.
AI Life Sciences Accelerator Mission:
A £100 million fund to bring academia, business, and the NHS together to drive AI uptake in life sciences.
2. Strategic Priorities:
Life Sciences as a Key Sector:
The UK government has identified life sciences as one of eight priority sectors for its industrial strategy, recognizing its potential to drive economic growth.
Focus on Innovation:
The government is emphasizing research and development, technology transfer, and commercialization to foster biotech innovation.
Attracting Global Investment:
The UK's industrial strategy aims to attract global investment in the life sciences sector, according to UK biotech financing 2024, to create a more supportive environment for biotech innovation.
3. Regulatory and Policy Support:
Regulatory Reform:
The government is working to reduce research red tape and streamline regulatory processes to allow scientists to focus on innovation.
R&D Tax Credits:
The government is considering measures like improved R&D tax credits and a "patent box" scheme to reduce the tax burden on companies taking new products into manufacturing.
NHS Procurement:
The government aims to better leverage the NHS's procurement power to support and grow commercial entities that serve national health needs.

[pgsd]

"the question is being asked should have no bearing on the timing of the process or the ultimate result"

You are correct in that sense however, it is still important that the issue is raised at the highest levels. I do not expect the health secretary in speaker's questions to commit to intervention or undermine the MHRA approval process but that does not mean that 'behind the scenes' conversations will not be held between himself and the MHRA. It is still important that these matters are given such attention regardless.

[improving]

It is Parliament's method of holding the government accountable. Very similar to Canada's parliament question proceedings. Question Time is an opportunity for MPs and Members of the House of Lords to question government ministers about matters for which they are responsible. Be glad for the interest for the mp's interest. I am.

[barnstormer]

You ask the questions for the same reason politicians everywhere ask questions - to raise public visibility and push to expedite action.

[KevGee59]

I would think the opposite.

If it's up this much with just this little tid-bit...how much do you think it will fly when approval gets announce?